All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

236

Reset

236 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AMT-162Phase 21 trial

    UniQure Biopharma B.V. · Amyotrophic Lateral Sclerosis

  • AP-101Phase 21 trial

    AL-S Pharma · Amyotrophic Lateral Sclerosis

  • AP-472Phase 21 trial

    Appello Pharmaceuticals, Inc. · Parkinson Disease

  • ARGX-119Phase 21 trial

    argenx · Spinal Muscular Atrophy (SMA)

  • AritinerceptPhase 21 trial

    Aurinia Pharmaceuticals Inc. · Myasthenia Gravis, Generalized

  • ATR 1072Phase 21 trial

    Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic

  • AV078Phase 21 trial

    Aeovian Pharmaceuticals, Inc. · Tuberous Sclerosis Complex, Epilepsy

  • BEY2153Phase 21 trial

    BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease

  • BHV-2100Phase 21 trial

    Biohaven Therapeutics Ltd. · Migraine

  • BIA 28-6156Phase 21 trial

    Bial R&D Investments, S.A. · Parkinson's Disease

  • BIIB091Phase 21 trial

    Biogen · Relapsing Forms of Multiple Sclerosis

  • BIIB147Phase 21 trial

    Biogen · Amyotrophic Lateral Sclerosis

  • BMS-986446Phase 21 trial

    Bristol Myers Squibb · Alzheimer Disease, Early Onset

  • BXQ-350SapC-DOPSPhase 21 trial

    Bexion Pharmaceuticals, Inc. · Metastatic Colorectal Carcinoma, Neuropathy

  • CB03-154Phase 21 trial

    Shanghai Zhimeng Biopharma, Inc. · Focal Epilepsy

  • CNP-106Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis

  • CORT113176DazucorilantPhase 21 trial

    Corcept Therapeutics · Amyotrophic Lateral Sclerosis

  • CPL500036Phase 21 trial

    Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced

  • DiranersenISIS 814907, BIIB080Phase 21 trial

    Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

  • DT-216P2Phase 21 trial

    Design Therapeutics, Inc. · Friedreich Ataxia

  • E2086Phase 21 trial

    Eisai · Narcolepsy

  • E2814Phase 21 trial

    Eisai · Alzheimer's Disease

  • EC5026Phase 21 trial

    EicOsis Human Health Inc. · Parkinson's Disease (PD)

  • EI-1071Phase 21 trial

    Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease

  • ER2001Phase 21 trial

    ExoRNA Bioscience · Huntington Disease

  • EX039Phase 21 trial

    Excelsior · Alzheimer Disease

  • exidavnemabPhase 21 trial

    BioArctic AB · Parkinson Disease, Multiple System Atrophy

  • FHND1002Phase 21 trial

    Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • ForalumabPhase 21 trial

    Tiziana Life Sciences LTD · Secondary Progressive Multiple Sclerosis

  • GB221Phase 21 trial

    Gemma Biotherapeutics · Spinal Muscular Atrophy Type I

  • GSK4527226Phase 21 trial

    GSK · Alzheimer's Disease

  • GT-02287GT-02287 400, GT-02287 800Phase 21 trial

    Gain Therapeutics, Inc. · Parkinson Disease

  • HT-4253Phase 21 trial

    Halia Therapeutics, Inc. · Alzheimers Disease

  • IRL757Phase 21 trial

    Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety

  • IVL3003Phase 21 trial

    Inventage Lab., Inc. · Alzheimer Disease

  • JNJ-64042056Phase 21 trial

    Johnson & Johnson (Janssen) · Alzheimer Disease

  • KDT-3594Phase 21 trial

    Kissei Pharmaceutical Co., Ltd. · Parkinson Disease

  • LHP588Phase 21 trial

    Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

  • LTX-002Phase 21 trial

    Leal Therapeutics, Inc · Amyotrophic Lateral Sclerosis

  • LY03015LPM3770164 sustained releasePhase 21 trial

    Luye Pharma Group Ltd. · Tardive Dyskinesia (TD)

  • LY3848575Phase 21 trial

    Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy

  • LY3884961Phase 21 trial

    Prevail Therapeutics · Parkinson Disease

  • MBF-015Phase 21 trial

    Medibiofarma S.L. · Huntington Disease

  • MEDI0618Phase 21 trial

    AbbVie · Migraine

  • MK-2214Phase 21 trial

    Merck & Co. · Early Alzheimer's Disease

  • MT101-5Phase 21 trial

    Mthera Pharma Co., Ltd. · Parkinson's Disease

  • MTX101Phase 21 trial

    Manistee Therapeutics · Migraine

  • NB-4746Phase 21 trial

    Nura Bio · Amyotrophic Lateral Sclerosis (ALS)

  • NBI-1065890Phase 21 trial

    Neurocrine Biosciences · Tardive Dyskinesia

  • NBI-1117567Phase 21 trial

    Neurocrine Biosciences · Alzheimer's Disease

NewerPage 4 of 5Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.